Office

Office on Smoking

#155,129
Most Influential Person Now

Office on Smoking's Academic­Influence.com Rankings

Office on Smoking
Medical
#3032
World Rank
#3483
Historical Rank
Public Health
#482
World Rank
#498
Historical Rank
medical Degrees
Download Badge
  • Medical

Why Is Office on Smoking Influential?

(Suggest an Edit or Addition)
(See a Problem?)

Office on Smoking's Published Works

Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
1990200020100250500750100012501500175020002250250027503000

Published Works

  • The Health Consequences of Smoking: A Report of the Surgeon General (2004) (2588)
  • How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General (2010) (1816)
  • The Health Consequences of Smoking (2004) (311)
  • Best practices for comprehensive tobacco control programs (1999) (191)
  • Tobacco use and cessation counselling: Global Health Professionals Survey Pilot Study, 10 countries, 2005 (2006) (106)
  • Trends in cigarette smoking among high school students--United States, 1991-2001. (2002) (88)
  • A cross country comparison of exposure to secondhand smoke among youth (2006) (71)
  • The Global Tobacco Surveillance System (2006) (35)
  • The Global School Personnel Survey: a cross-country overview (2006) (20)
  • Chemistry and Toxicology of Cigarette Smoke and Biomarkers of Exposure and Harm (2010) (19)
  • Table 7.3, Annual deaths, smoking attributable mortality (SAM), and years of potential life lost (YPLL), stratified by cause of death and gender, United States, 1995–1999 (2004) (11)
  • Figure 2.5, Cancer of the lung and bronchus: Surveillance, Epidemiology, and End Results (SEER) incidence rates by histologic type, gender, race, and ethnicity, all ages, 1973–1996 (2004) (10)
  • Reproductive and Developmental Effects (2010) (6)
  • Nicotine Addiction: Past and Present (2010) (6)
  • Introduction and Approach to Causal Inference (2004) (3)
  • The Impact of Smoking on Disease and the Benefits of Smoking Reduction (2004) (3)
  • Table 7.9, Replicated candidate gene associations in chronic obstructive pulmonary disease (COPD) (2010) (1)
  • Introduction, Evaluation of Evidence on Mechanisms of Disease Production, and Summary (2010) (1)
  • Figure 5.1, Link between cigarette smoking and cancer through carcinogens in tobacco smoke (2010) (1)
  • Table 7-1.1, Age-adjusted relative risks of death from smoking-related diseases from the Cancer Prevention Study (CPS) I and CPS-II, stratified by gender (2004) (1)
  • Table 6.10, Studies on the association between former smoking and medical services utilization costs and rates (2004) (0)
  • Table 6.15, Cross-sectional studies on the association between smoking status and bone density in women* (2004) (0)
  • Figure 3.4, Tobacco-specific nitrosamines (2010) (0)
  • Figure 4.6, Individual estimated slopes in craving ratings over three weeks prequit, from just before to just after midnight on the quit date, and over three weeks postquit (2010) (0)
  • Figure 5.10, Patterns of TP53 gene mutations and percentage of G→T transversion mutations in human lung cancers (2010) (0)
  • Figure 1.3, Potential pathways and mechanisms for cardiovascular dysfunction mediated by cigarette smoking (2010) (0)
  • Table 1.2, Causal criteria (2010) (0)
  • Table 7.3, Selected components of cigarette smoke and potential mechanisms of injury (2010) (0)
  • Table 5.9, Studies on the association between maternal smoking and premature rupture of membranes (2004) (0)
  • Table 2.1, Conclusions from previous Surgeon General’s reports concerning smoking as a cause of cancer* (2004) (0)
  • Table 4.11, Studies on the efficacy of antibiotic treatment in acute exacerbations of chronic obstructive pulmonary disease (2004) (0)
  • Table 2.30, Cohort studies on the association between the age at initiation of current smoking and the risk of colorectal cancer mortality* (2004) (0)
  • Figure 4.9, Negative affect in the days and hours preceding the first lapse for smokers who attributed their first lapse to a stressor or bad mood (stress trigger) or to some other type of event (other trigger) (2010) (0)
  • Table 4.1, Summary of subchronic exposure to cigarette smoke on immune function in animals* (2004) (0)
  • Table 2.37, Case-control studies on the association between smoking and the risk of breast cancer that used healthy controls drawn from population sources (2004) (0)
  • Figure 7.6, Dose-response relationship between level of smoking and the percentage of 408 patients in the St. Paul’s Lung Study with morphologic evidence of significant emphysema in their lungsa (2010) (0)
  • Figure 5.14, Tobacco-associated suppression of proapoptotic proteins and tumor-suppressor proteins (2010) (0)
  • Table 6.6, Smoking reduction and cardiovascular disease endpoints: biomarkers and clinical outcomes (2010) (0)
  • Table 5.4, Human DNA glycosylases (2010) (0)
  • Figure 2.2, Effects of smoking cessation at various ages on the cumulative risk (%) of death from lung cancer up to age 75, at death rates for men in United Kingdom in 1990 (2004) (0)
  • The Changing Cigarette (2010) (0)
  • Table 4.11, Lifetime and current prevalence of nicotine dependence in population studies in the United States (2010) (0)
  • Definitions and Alternative Nomenclature of Genetic Symbols Used in This Report (2010) (0)
  • Table 8.8, Basal maternal and fetal cardiovascular effects of smoking (2010) (0)
  • Table 2.10, Cohort studies on the association between current smoking, the number of cigarettes smoked per day, and the risk of esophageal cancer (2004) (0)
  • Figure 5.8, Proposed mechanism of nonhomologous end-joining (2010) (0)
  • Figure 4.5, The relationship between mean changes in forced expiratory volume in one second (FEV1) percent predicted to quintiles of mean changes in weight for each smoking category (2004) (0)
  • Table 4.16, Longitudinal studies on the association between smoking and adult asthma (2004) (0)
  • Table 7.8, Annual smoking attributable economic costs for adults and infants, United States, 1995–1999 (2004) (0)
  • Table 4.2, Studies on the effects of smoking on markers of human immune function and host defenses, derived from analyses of peripheral blood (2004) (0)
  • Figure 5.9, Model of mechanism for mammalian translesion synthesis (2010) (0)
  • Table 2.35, Studies on the association between smoking and the risk of liver cancer (2004) (0)
  • Table 6.29, Studies on the association between smoking and diabetic retinopathy (DR) (2004) (0)
  • Figure 2.3, Sales-weighted tar and nicotine values for U.S. cigarettes as measured by machine using the Federal Trade Commission (FTC) method, 1954–1998* (2004) (0)
  • Table 6.17, Cohort studies on the association between smoking status and the risk of bone loss in men and women (2004) (0)
  • Table 2.31, Cohort studies on the association between the number of years since or age at smoking cessation and the risk of colorectal cancer incidence or mortality* (2004) (0)
  • Table 2.9, Cohort studies on the association between smoking status and the risk of esophageal cancer* (2004) (0)
  • Table 4.7, Studies on the association between smoking and the occurrence of acute respiratory infections in persons with human immunodeficiency virus (HIV) infection (2004) (0)
  • Table 5.6, Studies on the association between maternal smoking and placenta previa (2004) (0)
  • Table 2.27, Cohort studies on the association between current smoking and the risk of colorectal cancer incidence or mortality* (2004) (0)
  • Table 5.4, Studies on the association between maternal smoking and ectopic pregnancy (2004) (0)
  • Table 5.6, Select candidate genes and polymorphisms implicated in repair of tobacco-induced DNA damage (2010) (0)
  • Table 4.6, Studies of candidate genes for nicotine metabolism and smoking behavior (2010) (0)
  • Table 4.5, Genetic linkage studies of smoking behavior phenotypes (2010) (0)
  • Figure 7.2, Fractional deposition of inhaled particles in the human respiratory tract (2010) (0)
  • Table 6.9, Studies on the association between the amount smoked and medical service utilization rates (2004) (0)
  • Table 7.6, Studies of oxidative stress in animals exposed to smoke (2010) (0)
  • Table 7-1.3, Smoking attributable mortality (deaths in thousands), all developed countries, 1985, stratified by age group, gender, and cause (2004) (0)
  • Table 3.1, Selected chronic carcinogenicity studies in mice and rats with inhalation exposure to cigarette smoke (2010) (0)
  • Table 6.4, Randomized controlled trials of counseling for smokers hospitalized with cardiovascular disease (2010) (0)
  • Table 4.2, Questions, answers, and scoring for Fagerström Test for Nicotine Dependence and Fagerström Tolerance Questionnaire (2010) (0)
  • Table 6.12, Studies comparing the health status of smokers and nonsmokers (2004) (0)
  • Table 7.4, Measurements of oxidative stress (2010) (0)
  • Table 4.10, Studies on the association between smoking, chronic obstructive pulmonary disease, and the risk of acute respiratory illness (ARI)—Results from the Tecumseh Study (2004) (0)
  • Table 2.14, Case-control studies on the association between smoking and the risk of esophageal cancer stratified by histologic type and years since smoking cessation (2004) (0)
  • Table 8.12, Reproductive and developmental effects of polycyclic aromatic hydrocarbons (PAHs), by endpoint (2010) (0)
  • Table 8.14, Decreased birth weight, preterm delivery, intrauterine growth retardation, and neonatal oxidative damage: interactions between host genotype and exposure to tobacco smoke (2010) (0)
  • Table 6.2, Death rates and rate ratios for death from coronary heart disease among men, by age and duration of smoking by number of cigarettes smoked per daya (2010) (0)
  • Table 6.11, Studies on the association between smoking and complications of surgery (2004) (0)
  • Table 4.9, Studies of candidate genes for serotonin and smoking behavior (2010) (0)
  • Figure 7.11, Lymphoid collections within lung tissue (2010) (0)
  • Table 5.3, Studies on the association between smoking and fertility in women (2004) (0)
  • Table 3.5, Studies on the association between smoking and the presence of subclinical cardiovascular disease using brain magnetic resonance imaging (2004) (0)
  • Table 4.12, Studies on the efficacy of antibiotic preventive treatment of persons with chronic obstructive pulmonary disease (2004) (0)
  • Table 6.4, Studies on the association between former smoking and white blood cell counts (2004) (0)
  • Table 2.22, Case-control studies on the association between the number of cigarettes smoked per day and the risk of stomach cancer* (2004) (0)
  • Table 6.7, Studies on the association between former smoking and absenteeism (2004) (0)
  • Table 6.22, Cross-sectional studies on the association between smoking and periodontitis (2004) (0)
  • Table 4.13, Conclusions from previous Surgeon General’s reports concerning smoking as a cause of chronic respiratory diseases (2004) (0)
  • Table 7.11, Estimated number of preventable smoking-related disease (SRD) deaths and Healthy People 2010* prevalence reduction goals, stratified by age, United States (2004) (0)
  • Figure 7.1, Schematic representation of the national model to estimate smoking-related expenditures for 1988 (2004) (0)
  • Table 2.2, Studies on the association between cigarette characteristics and lung cancer (2004) (0)
  • Figure 4.1, Theoretical curves depicting varying rates of decline of forced expiratory volume in one second (FEV1) (2004) (0)
  • Table 3.1, Basic pathogenic mechanisms in atherogenesis (2004) (0)
  • Figure 4.7, Reactions for the three-week period before the quit date and the three-week period after the quit date (2010) (0)
  • Figure 6.3, Dose-response relationship between number of cigarettes smoked per day and relative risk of ischemic heart disease (2010) (0)
  • Figure 5.2, Chemical structures of biomarkers of carcinogen exposure (2010) (0)
  • Table 6.13, Studies evaluating the dose-response relationship between the number of cigarettes smoked per day and health status (2004) (0)
  • Table 3.6, Studies on the association between smoking low-yield cigarettes and the risk of cardiovascular disease (CVD) (2004) (0)
  • Table 6.5, Studies on the percentage difference in white blood cell counts stratified by smoking patterns (2004) (0)
  • Table 5.11, Studies on the association between maternal smoking and congenital malformations (2004) (0)
  • Table 8.9, Maternal and fetal cardiovascular effects: radioisotope studies of placental intervillous blood flow (IBF) conducted before and after smoking (2010) (0)
  • Table 4.3, Measures of nicotine addiction (2010) (0)
  • Table 7.6, State age-adjusted smoking attributable mortality (SAM) rates per 100,000 persons, selected causes of death, United States, 1999 (2004) (0)
  • Table 8.6, Association between smoking and reproductive hormones in women (2010) (0)
  • Table 2.4, Case-control studies showing interactions between tobacco use, alcohol use, and the risk of laryngeal cancer (2004) (0)
  • Table 2.28, Case-control studies on the association between smoking status and the risk of colorectal cancer incidence (2004) (0)
  • Table 5.13, Studies on the association between maternal smoking and cognitive development, behavioral problems, and growth in children (2004) (0)
  • Figure 6.4, Plasma nicotine and carboxyhemoglobin concentrations throughout a day of cigarette smoking (2010) (0)
  • Table 5.8, Studies on the association between maternal smoking and preeclampsia (2004) (0)
  • Table 2.34, Cohort studies on the association between smoking and the risk of leukemia (2004) (0)
  • Table 6.26, Experimental studies on the association between smoking and erectile dysfunction (2004) (0)
  • Figure 7.1, Lung defenses (2010) (0)
  • Table 8.3, Association between maternal smoking and orofacial clefts (OFCs), 1999–2009a (2010) (0)
  • Figure 2.1, Scheme linking nicotine addiction and lung cancer via tobacco smoke carcinogens and their induction of multiple mutations in critical genes (2004) (0)
  • Table 6.21, Case-control studies on the association between smoking and periodontitis (2004) (0)
  • Figure 5.6, Mechanism of mismatch repair (2010) (0)
  • Table 2.33, Case-control studies on the association between smoking and the risk of leukemia (2004) (0)
  • Table 5.2, DNA adducts in human lung tissue (2010) (0)
  • Figure 3.5, Priority environmental polycyclic aromatic hydrocarbons (2010) (0)
  • Table 6.6, Studies on the association between current smoking and absenteeism (2004) (0)
  • Table 2.19, Cohort studies on the association between smoking status and the risk of stomach cancer* (2004) (0)
  • Figure 3.7, Primary heterocyclic amines in tobacco smoke (2010) (0)
  • Table 5.5, Factors involved in nucleotide excision repair activity in humans (2010) (0)
  • Table 2.39, Cohort studies on the association between smoking and the risk of breast cancer (2004) (0)
  • Figure 4.2, Mean plasma nicotine concentrations after administration of each of four smokeless tobacco products or mint snuff (2010) (0)
  • Table 6.3, Biomarkers of risk for cardiovascular disease from exposure to cigarette smoke (2010) (0)
  • Table 6.32, Studies on the association between smoking and peptic ulcer disease, allowing for Helicobacter pylori (H. pylori) infection (2004) (0)
  • Table 4.14, Studies on the association between maternal smoking during pregnancy and infant lung function (2004) (0)
  • Table 4.7, Studies of candidate genes for neuronal nicotine receptors and smoking behavior (2010) (0)
  • Figure 7.3, Comparison of normal bronchial gland (A) with enlarged bronchial glands (B and C) from a patient with chronic bronchitis (2010) (0)
  • Table 2.29, Cohort studies on the association between the duration of current smoking and the risk of colorectal cancer incidence or mortality* (2004) (0)
  • Table 2.20, Case-control studies on the association between smoking status and the risk of stomach cancer* (2004) (0)
  • Table 7.7, National medical expenditures and percentage of total health care expenditures attributable to cigarette smoking for adults, United States, 1993 (2004) (0)
  • Table 2.13, Cohort study on the association between smoking and the risk of esophageal cancer stratified by age at smoking cessation (2004) (0)
  • Table 5.11, Pathways altered through gene silencing by promoter methylation (2010) (0)
  • Figure 7.7, Postmortem bronchogram performed on the lungs of a person with centrilobular emphysema (2010) (0)
  • Figure 2.6, Stomach cancer death rates stratified by gender and per capita number of cigarettes smoked in the United States, 1930–1994 (2004) (0)
  • Figure 5.12, Concordance between codon distribution of G→T transversions along TP53 gene in lung cancers (top) and distribution of adducts of benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE)–DNA adducts in bronchial epithelial cells (bottom) (2010) (0)
  • Table 4.18, Studies on the association between cigarette tar yields and chronic respiratory diseases (2004) (0)
  • Figure 7.14, Diagram based on three-dimensional reconstructions of serial electron micrographs illustrating how inflammatory immune cells navigate through interstitial space of alveolar wall (2010) (0)
  • Figure 6.6, Potential sites of actions and mechanisms of effects of smoking on platelets (2010) (0)
  • Figure 7.10, Innate and adaptive immune system of the lung, including the mucous production and clearance apparatus, the epithelial barrier, and the inflammatory immune response (2010) (0)
  • Table 2.5, Cohort and case-control studies on the association between smoking status and the risk of cancers of the oral cavity and pharynx (2004) (0)
  • Table 7.4, Smoking attributable mortality in the United States, 1965–1999, stratified by gender* (2004) (0)
  • Table 2.8, Case-control studies on the association between smoking, alcohol use, and the risk of oropharyngeal cancer (2004) (0)
  • Figure 5.3, Metabolism of six carcinogens in tobacco smoke that produce DNA adducts identified in the lungs of smokers (2010) (0)
  • [Table, Infants and Children]. (2004) (0)
  • Table 2.25, Case-control studies on the association between smoking status and the risk of stomach cancer stratified by subsite (2004) (0)
  • Table 5.12, Studies on the association between maternal smoking and infant mortality (2004) (0)
  • Table 8.1, Association of adult cigarette smoking and in utero exposure to cigarette smoke with semen parameters and fertility in adultsa (2010) (0)
  • Table 6.28, Studies on the association between smoking and age-related macular degeneration (AMD) (2004) (0)
  • Figure 3.3, Three forms of nicotine (2010) (0)
  • Table 4.17, Cross-sectional studies on the association between smoking and adult asthma (2004) (0)
  • Table 9.1, Behavioral indicators of addiction potential of a drug or addiction to a drug (2010) (0)
  • Figure 7.18, Pathogenesis of smoking-induced pulmonary emphysema (2010) (0)
  • Figure 7.13, Remodeling process after a single clean surgical wound (2010) (0)
  • Figure 5.15, Protein-signaling pathways deregulated in lung cancer (2010) (0)
  • Table 5.7, Translesion-specialized DNA polymerases (pol) and activities on various DNA lesions (2010) (0)
  • Table 5.9, Frequency of mutation or deletion of tumor-suppressor genes in lung cancer (2010) (0)
  • Table 2.3, Case-control studies on the association between tobacco use and the risk of laryngeal cancer (2004) (0)
  • Figure 7.16, Synthesis of nitric oxide (NO) and related products (2010) (0)
  • Table 5.1, Conclusions from previous Surgeon General’s reports concerning smoking as a cause of reproductive effects (2004) (0)
  • Figure 7.5, Nature of an obstruction in the small conducting airways (<2 millimeters in diameter) (2010) (0)
  • Figure 1.1, The health consequences causally linked to smoking and exposure to secondhand smoke (2010) (0)
  • A Vision for the Future (2010) (0)
  • Figure 4.3, Mean change and 95 percent confidence interval in forced expiratory volume in one second (FEV1) percent predicted from years 1–5 of the Lung Health Study for sustained quitters, intermittent quitters, and continuous smokers, by quintile of age (2004) (0)
  • Table 6.27, Studies on the association between smoking and cataracts (2004) (0)
  • Table 2.26, Epidemiologic studies on the association between smoking status and the risk of colorectal adenoma (2004) (0)
  • Figure 7.4, Natural history of decline in forced expiratory volume with aging measured in a group of working men in West London over about six years (2010) (0)
  • Table 5.10, Studies on the association between maternal smoking, birth weight, and intrauterine growth retardation (2004) (0)
  • Table 1.1, Four-level hierarchy for classifying the strength of causal inferences from available evidence (2010) (0)
  • Table 7.2, Definitions for principal nonmalignant respiratory diseases caused by cigarette smoking (2010) (0)
  • Table 6.1, Conclusions from previous Surgeon General’s reports concerning smoking as a cause of diminished health status and respiratory morbidity (2004) (0)
  • Table 8.2, Association between maternal smoking and spontaneous abortion (SAB), 1998–2006 (2010) (0)
  • Table 3.7, Studies on the association between smoking and the risk of abdominal aortic aneurysm (AAA) (2004) (0)
  • Figure 1.2, General schema for the causation of disease by tobacco smoke (2010) (0)
  • Table 3.3, Studies on the association between smoking and atherosclerosis using the carotid B-mode ultrasound findings (2004) (0)
  • Figure 6.5, Overview of mechanisms by which cigarette smoking causes an acute cardiovascular event (2010) (0)
  • Figure 3.2, Structures of nicotine and minor alkaloid S(-)-N-methylanabasine in tobacco leaf (2010) (0)
  • Table 8.10, Acute maternal and fetal cardiovascular effects of smoking (2010) (0)
  • Figure 7.12, Persistent innate and adaptive immune inflammatory response in alveolar tissue (2010) (0)
  • Table 2.17, Case-control studies on the association between smoking and the risk of pancreatic cancer (2004) (0)
  • Figure 2.4, Age-specific death rates from lung cancer among current cigarette smokers and never smokers, based on smoking status at enrollment in Cancer Prevention Study I (CPS-I) or Cancer Prevention Study II (CPS-II), according to attained age (2004) (0)
  • Figure 3.1, Tobacco alkaloids (2010) (0)
  • Figure 4.1, Venous blood concentrations of nicotine over time for various nicotine delivery systems (2010) (0)
  • Table 7.12, Effects of protease inhibitors in experimental smoke-induced emphysema (2010) (0)
  • Table 7.5, State annual smoking attributable mortality (SAM) estimates, selected causes of death, United States, 1999 (2004) (0)
  • Table 8.4, Association between maternal smoking and cardiovascular malformations, by phenotype, 1999–2008 (2010) (0)
  • Figure 6.2, Age-specific excess death rates among male smokers for coronary heart disease, lung cancer, chronic obstructive pulmonary disease (COPD), and cerebrovascular disease (2010) (0)
  • Table 7.10, Matrix metalloproteinases in emphysema (2010) (0)
  • Table 2.24, Cohort and case-control studies on the association between years since quitting smoking and the risk of stomach cancer* (2004) (0)
  • Figure 4.5, Cumulative incidence curves of daily smoking and nicotine dependence in the National Comorbidity Survey (2010) (0)
  • Table 4.4, Studies on the association between smoking and the occurrence of influenza virus illness and infection (2004) (0)
  • Table 4.10, Other studies of candidate genes for smoking behavior (2010) (0)
  • Figure 6.1, Relative risk and excess death rate for coronary heart disease among men, by age group (2010) (0)
  • Figure 5.7, Proposed mechanism of homologous recombination (2010) (0)
  • Table 2.38, Case-control studies on the association between smoking and the risk of breast cancer conducted among screening program participants (2004) (0)
  • Figure 9.2, Molecular-profiling approaches to the development of personalized therapy (2010) (0)
  • Table 3.4, Studies on the association between smoking and clinical peripheral arterial disease using the ankle-arm index (AAI) (2004) (0)
  • Table 6.33, Studies on Helicobacter pylori (H. pylori) eradication rates among smokers and nonsmokers (2004) (0)
  • Figure 7.17, Oxidant and antioxidant systems in the lungs (2010) (0)
  • Figure 9.1, Effects on survival of stopping smoking cigarettes at ages 25–34 years (effect from age 35), ages 35–44 years (effect from age 40), ages 45–54 years (effect from age 50), and ages 55–64 years (effect from age 60) (2010) (0)
  • Table 6.19, Studies on the association between smoking and the risk of hip fractures in men and women reported since the 1997 meta-analysis by Law and Hackshaw (2004) (0)
  • Table 7.1, Disease burden measures used to evaluate the impact of population risk factors (2004) (0)
  • Table 7.5, Studies of oxidative stress in smokers (2010) (0)
  • Table 7.11, Mouse models of overexpression of a protein leading to emphysema (2010) (0)
  • Table 3.2, Markers of subclinical atherosclerosis used in epidemiologic studies (2004) (0)
  • Figure 7.15, Formation of reactive oxygen species (2010) (0)
  • Table 2.18, Studies on the association between smoking and the risk of endometrial cancer (2004) (0)
  • Table 5.1, IARC evaluations of carcinogens in mainstream cigarette smoke (2010) (0)
  • Table 6.20, Studies on the association between smoking and the risk of fractures at sites other than the hip in men and women (2004) (0)
  • Table 7-1.2, International Classification of Diseases (ICD) codes and comparability ratios* (CR) for smoking-related diseases, 1965–1999 (2004) (0)
  • Figure 6.3, Relative risk (95% confidence intervals) of hip fracture in smokers compared with nonsmokers in postmenopausal women according to age (2004) (0)
  • Table 4.4, Bioavailability and amount of nicotine absorbed per unit dose and time to maximum venous blood concentration of nicotine by product (2010) (0)
  • Figure 5.11, Patterns of TP53 gene mutations and percentage of G→T transversion mutations in different histologic types of lung cancer (2010) (0)
  • Figure 4.3, Associative learning processes in nicotine addiction (2010) (0)
  • Table 4.8, Studies of candidate genes for dopamine and smoking behavior (2010) (0)
  • Figure 7.8, Details of centrilobular emphysema lesions (2010) (0)
  • Table 6.31, Studies on the association between smoking and Graves’ ophthalmopathy (2004) (0)
  • Table 5.2, Studies on the association between smoking and sperm quality (2004) (0)
  • Figure 6.1, A conceptual model for the relationship between cigarette smoking and diminished health status (2004) (0)
  • Table 7.2, Annual prevalence of current smoking and former smoking among adults aged 35 years and older, selected years, National Health Interview Survey, United States, 1965–1999 (2004) (0)
  • Figure 4.6, Proportion (95 percent confidence interval) of participants reporting chronic cough at each annual follow-up visit, stratified by final smoking status (2004) (0)
  • Table 2.36, Case-control studies on the association between smoking and the risk of breast cancer that used hospital or cancer registry controls (2004) (0)
  • Table 4.8, Estimates of attributable risk fractions for smoking and acute respiratory illness (ARI) in persons without chronic obstructive pulmonary disease (2004) (0)
  • Table 5.8, Mutational specificity of selected DNA adducts derived from tobacco smoke (2010) (0)
  • Table 6.30, Studies on the association between smoking and glaucoma (2004) (0)
  • Table 6.8, Studies on the association between current smoking and medical service costs (2004) (0)
  • Table 2.40, Large case-control studies on the association between smoking and the risk of breast cancer published after 1993 (2004) (0)
  • [Table, Recommendations Addressing Tobacco Use Prevention and Treatment; Environmental Tobacco Smoke Exposure]. (2010) (0)
  • Table 2.16, Cohort studies on the association between tobacco use and the risk of pancreatic cancer (2004) (0)
  • Table 7.9, Smoking prevalence and the number of smokers in 2010 for alternative smoking reduction scenarios, stratified by age, United States (2004) (0)
  • Table 4.3, Studies on the effects of smoking on markers of human immune function and host defenses, derived from analyses of bronchoalveolar lavage fluid (2004) (0)
  • Table 1.1, Diseases and other adverse health effects for which smoking is identified as a cause in the current Surgeon General’s report (2004) (0)
  • Figure 4.4, Neural pathways for γ-aminobutyric acid, glutamate, dopamine, and excitatory neurotransmitters (2010) (0)
  • Table 7.8, Genomewide linkage analysis studies in general-population samples and in families with chronic obstructive pulmonary disease (COPD) (2010) (0)
  • Figure 6.7, Potential sites of effects of smoking on thrombosis through oxidative stress and other mechanisms (2010) (0)
  • Table 6.14, Studies comparing the health status of former smokers and nonsmokers (2004) (0)
  • Table 4.6, Studies on the association between smoking and the occurrence of acute upper respiratory illness (URI) and lower respiratory illness (LRI), with and without identification of specific pathogens (2004) (0)
  • Table 4.9, Studies on the association between smoking and the risk of acute respiratory illness (ARI)— Results from the Tecumseh Study (2004) (0)
  • Table 2.6, Cohort and case-control studies on the association between current smoking, the number of cigarettes smoked per day, and the risk of oropharyngeal cancer (2004) (0)
  • Table 2.7, Cohort and case-control studies on the association between former smoking, the number of years since quitting, and the risk of oropharyngeal cancer (2004) (0)
  • Table 5.5, Studies on the association between maternal smoking and spontaneous abortion (2004) (0)
  • Table 5.12, Carcinogens and tobacco-induced cancers (2010) (0)
  • Table 7.7, In vitro studies of oxidative stress (2010) (0)
  • Table 6.24, Cross-sectional and cohort studies on the association between smoking and dental caries (2004) (0)
  • Table 8.7, Association between smoking and reproductive hormones in healthy men (2010) (0)
  • Table 4.15, Studies on the association between smoking and rates of forced expiratory volume in one second (FEV1) decline (2004) (0)
  • Table 5.3, Selected gene polymorphisms evaluated by molecular epidemiology investigations for relationship to lung cancer through variation in susceptibility to carcinogens in tobacco smoke (2010) (0)
  • Figure 6.2, Differences (95% confidence intervals), as a proportion of 1 standard deviation (SD), in bone mineral density between female smokers and nonsmokers according to age and menopausal status (2004) (0)
  • Table 8.11, Animal and in vitro studies on association between maternal smoking and congenital abnormalities with relevant genetic and/or molecular hypotheses (2010) (0)
  • Table 5.10, Frequency of gene amplification and increased expression of genes in lung cancer (2010) (0)
  • Table 6.1, Rate ratios for coronary heart disease among White men, by age and duration of cigarette smokinga (2010) (0)
  • Table 4.12, Prevalence of selected symptoms of nicotine dependence reported in selected studies (2010) (0)
  • Table 6.23, Cohort studies on the association between smoking and periodontitis (2004) (0)
  • Table 6.16, Studies on the association between smoking status and bone density in men and women published since the 1997 meta-analysis by Law and colleagues (2004) (0)
  • Table 6.25, Cross-sectional studies on the association between smoking and the risk of erectile dysfunction (ED) (2004) (0)
  • Table 4.5, Studies on the association between smoking and the occurrence of pneumonia and infection with pathogens that infect the lower respiratory tract (2004) (0)
  • Table 7.10, Low-, middle-, and high-range estimates of proportions of smoking-related disease (SRD) deaths and preventable deaths among current smokers, stratified by age, United States (2004) (0)
  • Figure 5.5, Mechanism of nucleotide excision repair: (A) global genomic repair; (B) transcription-coupled repair (2010) (0)
  • Table 2.12, Case-control studies on the association between current smoking, the number of cigarettes smoked per day, and the risk of esophageal cancer stratified by histologic type (2004) (0)
  • Figure 4.2, Summary diagram of cigarette-related mechanisms of lung injury (2004) (0)
  • Table 6.5, Randomized controlled trials of pharmacologic interventions for smoking cessation in patients with cardiovascular disease (2010) (0)
  • Figure 7.9, Cut surface of lungs removed from two patients with different forms of emphysema before receiving a lung transplant (2010) (0)
  • Table 5.7, Studies on the association between maternal smoking and placental abruption (2004) (0)
  • Table 7.1, Causal conclusions on smoking and diseases of the respiratory tract other than lung cancer: the 2004 and 2006 reports of the Surgeon General (2010) (0)
  • Figure 2.7, Results on tobacco consumption and breast cancer in women who reported drinking no alcohol (2004) (0)
  • Figure 3.6, Commonly studied aromatic amines in tobacco smoke (2010) (0)
  • Table 2.32, Cohort studies on the association between smoking status and behavior and the risk of prostate cancer incidence or mortality (2004) (0)
  • Table 6.2, Studies on the association between smoking and oxidative injury (2004) (0)
  • Figure 4.8, Withdrawal severity and lapse behavior among smokers who abstained for the first five days of a quit attempt (2010) (0)
  • Table 1.2, Variations in terminology from previous Surgeon General’s reports concerning smoking as a cause of the listed diseases* (2004) (0)
  • Table 2.23, Cohort studies on the association between current smoking, years of smoking, and the risk of stomach cancer* (2004) (0)
  • Figure 5.13, Patterns of TP53 gene mutations and percentage of G→T transversions in smoking-associated cancers other than lung cancer (2010) (0)
  • Table 2.11, Case-control studies on the association between smoking status and the risk of esophageal cancer stratified by histologic type (2004) (0)
  • Table 4.1, Criteria for substance (nicotine) dependence (2010) (0)
  • Table 8.5, Association between maternal smoking and noncardiovascular congenital malformations, by type of malformation, 1998–2008 (2010) (0)
  • Figure 5.4, Mechanism of base excision repair (2010) (0)
  • Table 8.13, Studies of interactions between genotype and exposure to tobacco related to oral clefting (2010) (0)

This paper list is powered by the following services:

Metadata from Crossref logo